miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the eighth most common cancer worldwide and is one of the most lethal malignancies. Cisplatin (DDP) is a key drug for ESCC treatment, but the presence of chemotherapy resistance limits the use of DDP. To enhance chemosensitivity to DDP is impo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Cell Int
Päätekijät: Zheng, Tian-Liang, Li, De-Ping, He, Zhan-Feng, Zhao, Song
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Primary Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767650/
https://ncbi.nlm.nih.gov/pubmed/31582906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0943-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia